0000902664-24-002545.txt : 20240321 0000902664-24-002545.hdr.sgml : 20240321 20240321171404 ACCESSION NUMBER: 0000902664-24-002545 CONFORMED SUBMISSION TYPE: DFAN14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240321 DATE AS OF CHANGE: 20240321 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Health Sciences Term Trust CENTRAL INDEX KEY: 0001785971 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DFAN14A SEC ACT: 1934 Act SEC FILE NUMBER: 811-23466 FILM NUMBER: 24772302 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: 800 882 0052 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock Health Sciences Trust II DATE OF NAME CHANGE: 20190820 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Saba Capital Management, L.P. CENTRAL INDEX KEY: 0001510281 ORGANIZATION NAME: IRS NUMBER: 800361690 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DFAN14A BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: 212-542-4635 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 DFAN14A 1 p24-1266dfan14a.htm BLACKROCK HEALTH SCIENCES TERM TRUST

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934

 

Filed by the Registrant ¨

 

Filed by a Party other than the Registrant þ

 

Check the appropriate box:

 

¨ Preliminary Proxy Statement
¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ Definitive Proxy Statement
¨ Definitive Additional Materials
þ Soliciting Material Under Rule 14a-12

 

BlackRock Health Sciences Term Trust

 

(Name of Registrant as Specified In Its Charter)

 

Saba Capital Management, L.P.

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 
 

 

 

Payment of Filing Fee (Check all boxes that apply):

 

þ No fee required.
   
¨ Fee paid previously with preliminary materials.

 

¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

 

 
 

 

Boaz R. Weinstein retweeted the following message to his X account:

 

As I have stated before, the two crazy parts of this is

 

1) BlackRock has a fiduciary to do what is best for fund shareholder but they keep fighting in court proposals that actually benefit shareholders

 

2) this is common sense. Shareholders rights are not some holistic practice. It’s the underlying foundation that makes American markets better than any other countries. BlackRock is literally creating obstacles that squash shareholders rights